title: Noncardiogenic pulmonary edema in a patient receiving vancomycin and oxycodone-acetaminophen.
authors.forename: B Gabriel
authors.initials: BG
authors.lastname: Smolarz
authors.forename: Jacqueline
authors.initials: J
authors.lastname: Ross
authors.forename: Eric
authors.initials: E
authors.lastname: Sachinwalla
authors.forename: Akiva
authors.initials: A
authors.lastname: Marcus
authors.forename: Daniel T
authors.initials: DT
authors.lastname: Abazia
mesh_terms: D000081:Acetamides / Q000627:therapeutic use; D000082:Acetaminophen / Q000009:adverse effects* / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002481:Cellulitis / Q000188:drug therapy; D004155:Diphenhydramine / Q000627:therapeutic use; D004338:Drug Combinations; D015738:Famotidine / Q000627:therapeutic use; D005665:Furosemide / Q000627:therapeutic use; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D023303:Oxazolidinones / Q000627:therapeutic use; D010098:Oxycodone / Q000009:adverse effects* / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D013207:Staphylococcal Skin Infections / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects; D016896:Treatment Outcome; D014640:Vancomycin / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000081:Acetamides; D000700:Analgesics; D000890:Anti-Infective Agents; D004338:Drug Combinations; D023303:Oxazolidinones; C514822:oxycodone-acetaminophen; D000082:Acetaminophen; D015738:Famotidine; D014640:Vancomycin; D005665:Furosemide; D004155:Diphenhydramine; D010098:Oxycodone; D000069349:Linezolid